JP2006501187A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006501187A5 JP2006501187A5 JP2004520018A JP2004520018A JP2006501187A5 JP 2006501187 A5 JP2006501187 A5 JP 2006501187A5 JP 2004520018 A JP2004520018 A JP 2004520018A JP 2004520018 A JP2004520018 A JP 2004520018A JP 2006501187 A5 JP2006501187 A5 JP 2006501187A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- inhibitors
- agent
- alkyl
- structural formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C***(C)C1CCCC1 Chemical compound C***(C)C1CCCC1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39455302P | 2002-07-09 | 2002-07-09 | |
| PCT/US2003/021331 WO2004004655A2 (en) | 2002-07-09 | 2003-07-08 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006501187A JP2006501187A (ja) | 2006-01-12 |
| JP2006501187A5 true JP2006501187A5 (https=) | 2006-08-31 |
| JP4541883B2 JP4541883B2 (ja) | 2010-09-08 |
Family
ID=30115733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004520018A Expired - Fee Related JP4541883B2 (ja) | 2002-07-09 | 2003-07-08 | 抗糖尿病薬および抗肥満症薬として有用な置換へテロ環誘導体、並びに方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6875782B2 (https=) |
| EP (1) | EP1531810B1 (https=) |
| JP (1) | JP4541883B2 (https=) |
| KR (1) | KR101120337B1 (https=) |
| CN (1) | CN1665500A (https=) |
| AT (1) | ATE543497T1 (https=) |
| AU (1) | AU2003248861B2 (https=) |
| BR (1) | BR0312503A (https=) |
| CA (1) | CA2490972C (https=) |
| ES (1) | ES2380319T3 (https=) |
| GE (1) | GEP20084475B (https=) |
| HR (1) | HRP20050001A2 (https=) |
| IL (1) | IL165809A (https=) |
| IS (1) | IS7629A (https=) |
| MX (1) | MXPA05000279A (https=) |
| NO (1) | NO329328B1 (https=) |
| NZ (1) | NZ537251A (https=) |
| PL (1) | PL375230A1 (https=) |
| RS (1) | RS20050002A (https=) |
| RU (1) | RU2325381C2 (https=) |
| UA (1) | UA79296C2 (https=) |
| WO (1) | WO2004004655A2 (https=) |
| ZA (1) | ZA200500029B (https=) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE372770T1 (de) * | 2002-08-01 | 2007-09-15 | Neurosearch As | Verbindungen nützlich in der behandlung von erkrankungen die auf anti-angiogenertherapie antworten |
| MY142651A (en) | 2003-03-18 | 2010-12-15 | Merck Sharp & Dohme | Biaryl substituted triazoles as sodium channel blockers |
| US20060183897A1 (en) * | 2003-03-18 | 2006-08-17 | Chakravarty Prasun K | Biaryl substituted triazoles as sodium channel blockers |
| CA2518465A1 (en) | 2003-03-25 | 2004-10-14 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| JP2007511467A (ja) | 2003-05-14 | 2007-05-10 | タケダ サン ディエゴ インコーポレイテッド | ジペプチジルペプチダーゼインヒビター |
| KR20060041309A (ko) | 2003-08-13 | 2006-05-11 | 다케다 야쿠힌 고교 가부시키가이샤 | ４-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도 |
| FR2861303A1 (fr) * | 2003-10-24 | 2005-04-29 | Sanofi Synthelabo | Utilisation d'un derive de pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique |
| FR2861300B1 (fr) * | 2003-10-24 | 2008-07-11 | Sanofi Synthelabo | Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique |
| FR2861301B1 (fr) * | 2003-10-24 | 2008-07-11 | Sanofi Synthelabo | Utilisation du derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique. |
| FR2861302A1 (fr) * | 2003-10-24 | 2005-04-29 | Sanofi Synthelabo | Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique. |
| CN1882327A (zh) * | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| KR101494067B1 (ko) | 2004-03-05 | 2015-02-16 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 부작용을 최소화하면서 과지질혈증 및 과콜레스테롤혈증과 연관된 질환 또는 질병의 치료 방법 |
| WO2005115384A2 (en) * | 2004-05-25 | 2005-12-08 | Metabolex, Inc. | Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| CN1997633A (zh) * | 2004-05-25 | 2007-07-11 | 麦它波莱克斯股份有限公司 | 作为ppar调节剂的取代的三唑及其制备方法 |
| WO2006032042A2 (en) * | 2004-09-15 | 2006-03-23 | Regeneron Pharmaceuticals, Inc. | Us of cntf or a cntf derivative in combination with a further compound for the preparation of medicament for the treatment of obesity |
| EP1807070A1 (en) * | 2004-09-29 | 2007-07-18 | Schering Corporation | Combinations of substituted azetidinones and cb1 antagonists |
| EP1866298A2 (en) * | 2005-03-31 | 2007-12-19 | Takeda San Diego, Inc. | Hydroxysteroid dehydrogenase inhibitors |
| WO2006117743A1 (en) * | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | Substituted aromatic compounds as antidiabetic agents |
| WO2006128056A2 (en) * | 2005-05-26 | 2006-11-30 | Metabasis Therapeutics, Inc. | Novel phosphinic acid-containing thyromimetics |
| MX2007014502A (es) | 2005-05-26 | 2008-02-07 | Metabasis Therapeutics Inc | Tiromimeticos para el tratamiento de enfermedades del higado graso. |
| FR2889191A1 (fr) * | 2005-07-28 | 2007-02-02 | Cerep Sa | Composes derives de 5-benzylidene imidazolidine 2,4-dione et leur utilisation en tant qu'antagonistes de mchr-1 |
| MY147393A (en) | 2005-09-14 | 2012-11-30 | Takeda Pharmaceutical | Administration of dipeptidyl peptidase inhibitors |
| CA2622642C (en) | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| AU2006304689A1 (en) * | 2005-10-18 | 2007-04-26 | Aegerion Pharmaceuticals | Compositions for lowering serum cholesterol and/or triglycerides |
| MX2008015228A (es) * | 2006-05-30 | 2008-12-12 | Astrazeneca Ab | Acido 5-fenilamino-1,3,4-oxadiazol-2-ilcarbonilamino-4-fenoxi-cicl ohexanocarboxilico sustituido como inhibidor de diacilglicerol aciltransferasa de acetil coenzima a. |
| CN101460470B (zh) * | 2006-05-30 | 2011-05-18 | 阿斯利康(瑞典)有限公司 | 作为dgat1抑制剂的1,3,4-二唑衍生物 |
| US20080009534A1 (en) * | 2006-07-07 | 2008-01-10 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| US8217025B2 (en) * | 2006-11-17 | 2012-07-10 | Harbor Therapeutics, Inc. | Drug screening and treatment methods |
| TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| JP2010513534A (ja) * | 2006-12-21 | 2010-04-30 | エージェリオン ファーマシューティカルズ， インコーポレイテッド | Ｍｔｐインヒビターおよびコレステロール吸収インヒビターを含む組み合わせを用いて肥満症を処置する方法 |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| TW200906823A (en) | 2007-07-16 | 2009-02-16 | Lilly Co Eli | Compounds and methods for modulating FXR |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CN103694195B (zh) * | 2013-09-18 | 2016-04-06 | 华东师范大学 | 芳香杂环类小分子有机化合物及衍生物、制备方法及医药用途 |
| EP3190103A1 (en) * | 2016-01-08 | 2017-07-12 | Rijksuniversiteit Groningen | Inhibitors of the pd-1/pd-l1 protein/protein interaction |
| JP2020500199A (ja) | 2016-11-21 | 2020-01-09 | バイキング・セラピューティクス・インコーポレイテッド | グリコーゲン蓄積症の治療方法 |
| AU2018280118B2 (en) | 2017-06-05 | 2021-07-15 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| KR101943382B1 (ko) | 2017-09-19 | 2019-01-29 | 오토텔릭바이오 주식회사 | Sglt-2 저해제 및 안지오텐신 수용체 차단제를 포함하는 의약 조성물 |
| ES3053674T3 (en) | 2018-03-22 | 2026-01-23 | Viking Therapeutics Inc | Crystalline forms and methods of producing crystalline forms of a compound |
| GB201810486D0 (en) * | 2018-06-26 | 2018-08-08 | Imperial Innovations Ltd | Natural killer cells |
| KR102131359B1 (ko) * | 2018-09-07 | 2020-07-07 | 오토텔릭바이오 주식회사 | 안정성이 향상된 의약 조성물 |
| WO2020117962A1 (en) | 2018-12-05 | 2020-06-11 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis and inflammation |
| CA3186856A1 (en) | 2020-07-29 | 2022-02-03 | Ruth NALLEN | Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69427023T2 (de) | 1993-12-28 | 2001-10-31 | Meiji Seika K.K., Tokio/Tokyo | Tricyclische benzazepin-und benzothiazepin derivate |
| JPH10501222A (ja) * | 1994-05-27 | 1998-02-03 | メルク エンド カンパニー インコーポレーテッド | 破骨細胞仲介骨吸収を抑制するための化合物 |
| JP3537446B2 (ja) | 1995-06-15 | 2004-06-14 | 明治製菓株式会社 | 三環性ベンゾアゼピン化合物 |
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| JP3215048B2 (ja) * | 1996-04-03 | 2001-10-02 | 日本たばこ産業株式会社 | プロピオン酸誘導体及びその用途 |
| JPH1067759A (ja) | 1996-06-20 | 1998-03-10 | Sankyo Co Ltd | 除草性アゾール誘導体 |
| JPH11263775A (ja) | 1997-09-08 | 1999-09-28 | Sankyo Co Ltd | ヒドロキシアニリン誘導体 |
| ES2191963T3 (es) | 1997-09-29 | 2003-09-16 | Meiji Seika Kaisha | Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos. |
| ATE451346T1 (de) * | 1998-03-10 | 2009-12-15 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
| FR2778314B1 (fr) | 1998-05-07 | 2002-06-14 | Rhone Poulenc Agrochimie | Composition fongicide synergique comprenant un compose analogue de la strobilurine |
| GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| ATE260912T1 (de) | 1999-09-08 | 2004-03-15 | Glaxo Group Ltd | Oxazol ppar antagonisten |
| TWI302149B (en) * | 1999-09-22 | 2008-10-21 | Bristol Myers Squibb Co | Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method |
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| IL149493A0 (en) | 1999-11-10 | 2002-11-10 | Takeda Chemical Industries Ltd | 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| GB0029974D0 (en) * | 2000-12-08 | 2001-01-24 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-07-08 BR BRPI0312503-3A patent/BR0312503A/pt not_active IP Right Cessation
- 2003-07-08 CN CN038160382A patent/CN1665500A/zh active Pending
- 2003-07-08 MX MXPA05000279A patent/MXPA05000279A/es active IP Right Grant
- 2003-07-08 CA CA2490972A patent/CA2490972C/en not_active Expired - Fee Related
- 2003-07-08 AT AT03763345T patent/ATE543497T1/de active
- 2003-07-08 PL PL03375230A patent/PL375230A1/xx not_active Application Discontinuation
- 2003-07-08 NZ NZ537251A patent/NZ537251A/en not_active IP Right Cessation
- 2003-07-08 EP EP03763345A patent/EP1531810B1/en not_active Expired - Lifetime
- 2003-07-08 JP JP2004520018A patent/JP4541883B2/ja not_active Expired - Fee Related
- 2003-07-08 KR KR1020057000362A patent/KR101120337B1/ko not_active Expired - Fee Related
- 2003-07-08 AU AU2003248861A patent/AU2003248861B2/en not_active Ceased
- 2003-07-08 RU RU2005103395/04A patent/RU2325381C2/ru not_active IP Right Cessation
- 2003-07-08 GE GEAP8617A patent/GEP20084475B/en unknown
- 2003-07-08 US US10/616,283 patent/US6875782B2/en not_active Expired - Lifetime
- 2003-07-08 ES ES03763345T patent/ES2380319T3/es not_active Expired - Lifetime
- 2003-07-08 RS YUP-2005/0002A patent/RS20050002A/sr unknown
- 2003-07-08 WO PCT/US2003/021331 patent/WO2004004655A2/en not_active Ceased
- 2003-07-08 HR HR20050001A patent/HRP20050001A2/hr not_active Application Discontinuation
- 2003-08-07 UA UAA200501187A patent/UA79296C2/uk unknown
-
2004
- 2004-12-16 IL IL165809A patent/IL165809A/en not_active IP Right Cessation
- 2004-12-17 NO NO20045529A patent/NO329328B1/no not_active IP Right Cessation
- 2004-12-17 US US11/016,183 patent/US7507757B2/en not_active Expired - Lifetime
-
2005
- 2005-01-03 ZA ZA200500029A patent/ZA200500029B/xx unknown
- 2005-01-05 IS IS7629A patent/IS7629A/is unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006501187A5 (https=) | ||
| CA2490972A1 (en) | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | |
| JP2004536070A5 (https=) | ||
| CA2366871A1 (en) | Heterocyclic containing biphenyl ap2 inhibitors and method | |
| JP4332315B2 (ja) | 抗糖尿病剤および抗肥満剤として有用な置換酸誘導体および方法 | |
| DE02729306T1 (de) | Substituierte azolsäurederivate, die sich als mittel gegen diabetes und obesitas eignen, und verfahren | |
| EP2365808B1 (en) | Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury | |
| JP4579681B2 (ja) | 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法 | |
| US6414002B1 (en) | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | |
| JP2004500416A5 (https=) | ||
| CA2388818A1 (en) | C-aryl glucoside sglt2 inhibitors and method | |
| EA010026B1 (ru) | 4-биарилил-1-фенилазетидин-2-оны | |
| JP2003511458A5 (https=) | ||
| RU2003101064A (ru) | Ингибиторы hmg-coa редуктазы | |
| RU2010102990A (ru) | Производные оксадиазолов в качестве ингибиторов dgat | |
| RU2002125491A (ru) | Ингибиторы дипептидилпептидазы IV на основе конденсированных циклопропилпирролидинов и способ их применения | |
| JP2005502600A5 (https=) | ||
| JP2004536115A5 (https=) | ||
| JP2009537524A5 (https=) | ||
| RU99101081A (ru) | Режим введения ингибиторов н+, к+-атфазы | |
| EP2136637B1 (en) | Inhibitors of cholesterol ester transfer protein | |
| JP6302937B2 (ja) | ２−（（１ｒ，４ｒ）−４−（４−（５−（ベンゾオキサゾール−２−イルアミノ）ピリジン−２−イル）フェニル）シクロヘキシル）酢酸のメグルミン塩形態、およびｄｇａｔ１阻害剤としてのそれらの使用 | |
| CN115244043B (zh) | 作为trpv1拮抗剂的苯并咪唑酮基肉桂酰胺衍生物和含有其作为活性成分的用于治疗或预防疼痛的药物组合物 | |
| RU2012153702A (ru) | Соединения, обладающие активирующим действием на подтипы рецепторов, активируемых пролифератором пероксисом (ppars), и способ получения и применения указанных соединений | |
| RU2001129702A (ru) | Содержащие гетероцикл бифенил ингибиторы aP2 |